GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » FCF Yield %

Clearmind Medicine (Clearmind Medicine) FCF Yield % : -77.10 (As of May. 22, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Clearmind Medicine's Trailing 12-Month Free Cash Flow is $-2.92 Mil, and Market Cap is $3.78 Mil. Therefore, Clearmind Medicine's FCF Yield % for today is -77.10%.

The historical rank and industry rank for Clearmind Medicine's FCF Yield % or its related term are showing as below:

CMND' s FCF Yield % Range Over the Past 10 Years
Min: -422.17   Med: 0   Max: 0
Current: -77.1


CMND's FCF Yield % is ranked worse than
81.88% of 1556 companies
in the Biotechnology industry
Industry Median: -14.16 vs CMND: -77.10

Clearmind Medicine's FCF Margin % for the quarter that ended in Jan. 2024 was 0.00%.


Clearmind Medicine FCF Yield % Historical Data

The historical data trend for Clearmind Medicine's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine FCF Yield % Chart

Clearmind Medicine Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
FCF Yield %
Get a 7-Day Free Trial - - -8.15 -26.29 -205.17

Clearmind Medicine Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -140.29 4.94 -144.45 -66.82 -129.02

Competitive Comparison of Clearmind Medicine's FCF Yield %

For the Biotechnology subindustry, Clearmind Medicine's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clearmind Medicine's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearmind Medicine's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Clearmind Medicine's FCF Yield % falls into.



Clearmind Medicine FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Clearmind Medicine's FCF Yield % for the fiscal year that ended in Oct. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-4.557 / 2.22104238
=-205.17%

Clearmind Medicine's annualized FCF Yield % for the quarter that ended in Jan. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.462 * 4 / 4.5324851
=-129.02%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clearmind Medicine FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Clearmind Medicine FCF Yield % Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Clearmind Medicine (Clearmind Medicine) Business Description

Traded in Other Exchanges
Address
101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.